APPRAISAL O F GUIDELINES
|
|
- Veronica Barnett
- 6 years ago
- Views:
Transcription
1 APPRAISAL O F GUIDELINES F OR RESEARCH & EVALUATIO N INSTRU MENT The AGREE Collaboration September 2001
2 C O PYRI G H T A N D REPR O D U C TI O N This document is the product of an international collaboration. It may be reproduced and used for educational purposes, quality assurance programmes and critical appraisal of clinical practice guidelines. It may not be used for commercial purposes or product marketing. Approved non-english language versions of the AGREE Instrument are being prepared, and must be used where available. Offers of assistance in translation into other languages are welcome, provided they conform to the protocol set out by the AGREE Collaboration. DISCLAIMER The AGREE Instrument is a generic tool designed primarily to help guideline developers and users assess the methodological quality of clinical practice guidelines. The authors do not take responsibility for the improper use of the AGREE Instrument. St George s Hospital Medical School, London, June 2001 Reprinted with amendments September 2001 ISBN X SUGGESTED CITATIO N: The AGREE Collaboration. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. FUN DIN G: The development of the AGREE Instrument was funded by a grant from the EU BIO MED2 Programme (BMH ) FOR FURTHER INFORMATIO N ABOUT THE INSTRUMENT C O NTACT: Françoise Cluzeau f.cluzeau@sghms.ac.uk or Jako Burgers j.burgers@hsv.kun.nl Typeset by CA Group, London
3 I N TR O D U C TI O N Purpose of the AGREE Instrument. The purpose of the Appraisal of Guidelines Research & Evaluation (AGREE) Instrument is to provide a framework for assessing the quality of clinical practice guidelines. Clinical practice guidelines are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances 1. Their purpose is to make explicit recommendations with a definite intent to influence what clinicians do 2. By quality of clinical practice guidelines we mean the confidence that the potential biases of guideline development have been addressed adequately and that the recommendations are both internally and externally valid, and are feasible for practice. This process involves taking into account the benefits, harms and costs of the recommendations, as well as the practical issues attached to them. Therefore, the assessment includes judgements about the methods used for developing the guidelines, the content of the final recommendations, and the factors linked to their uptake. The AGREE Instrument assesses both the quality of the reporting, and the quality of some aspects of recommendations. It provides an assessment of the predicted validity of a guideline, that is the likelihood that it will achieve its intended outcome. It does not assess the impact of a guideline on patients outcomes. Most of the criteria contained in the AGREE Instrument are based on theoretical assumptions rather than on empirical evidence. They have been developed through discussions between researchers from several countries who have extensive experience and knowledge of clinical guidelines. Thus, the AGREE Instrument should be perceived as reflecting the current state of knowledge in the field. Which guidelines can be appraised with the AGREE Instrument. The AGREE Instrument is designed to assess guidelines developed by local, regional, national or international groups or affiliated governmental organisations. These include: 1. New guidelines 2. Existing guidelines 3. Updates of existing guidelines The AGREE Instrument is generic and can be applied to guidelines in any disease area including those for diagnosis, health promotion, treatment or interventions. It is suitable for guidelines presented in paper or electronic format. 1 Lohr KN, Field MJ. A provisional instrument for assessing clinical practice guidelines. In: Field MJ, Lohr KN (eds). Guidelines for clinical practice. From development to use. Washington D.C. National Academy Press, Hayward RSA, Wilson M C, Tunis SR, Bass EB, Guyatt G, for the Evidence-Based Medicine Working Group. Users guides to the Medical Literature. VIII. How to Use Clinical Practice Guidelines. A. Are the Recommendations Valid? JAMA, 1995;274,
4 I N TR O D U C TI O N Who can use the AGREE Instrument? The AGREE Instrument is intended to be used by the following groups: i) By policy makers to help them decide which guidelines could be recommended for use in practice. In such instances, the instrument should be part of a formal assessment process. ii) By guideline developers to follow a structured and rigorous development methodology and as a selfassessment tool to ensure that their guidelines are sound. iii) By health care providers who wish to undertake their own assessment before adopting the recommendations iv) By educators or teachers to help enhance critical appraisal skills amongst health professionals. Key references The following sources have been used for developing the AGREE Instrument criteria. Lohr KN, Field MJ. A provisional instrument for assessing clinical practice guidelines. In: Field MJ, Lohr KN (eds). Guidelines for clinical practice. From development to use. Washington D.C. National Academy Press, Cluzeau F, Littlejohns P, Grimshaw J, Feder G, Moran S. Development and application of a generic methodology to assess the quality of clinical guidelines. International Journal for Q uality in Health Care 1999;11: Grol R, Dalhuijzen J, Mokkink H, Thomas S, Veld C, Rutten G. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 1998;317: Lohr KN. The quality of practice guidelines and the quality of health care. In: Guidelines in health care. Report of a WH O Conference. January 1997, Baden-Baden: N omos Verlagsgesellschaft,
5 I N STRU C TI O N S F O R USE Please read the following instructions carefully before using the AGREE Instrument. 1. Structure and content of the AGREE Instrument AGREE consists of 23 key items organised in six domains. Each domain is intended to capture a separate dimension of guideline quality. Scope and purpose (items 1-3) is concerned with the overall aim of the guideline, the specific clinical questions and the target patient population. Stakeholder involvement (items 4-7) focuses on the extent to which the guideline represents the views of its intended users. Rigour of development (items 8-14) relates to the process used to gather and synthesise the evidence, the methods to formulate the recommendations and to update them. Clarity and presentation (items 15-18) deals with the language and format of the guideline. Applicability (items 19-21) pertains to the likely organisational, behavioural and cost implications of applying the guideline. Editorial independence (items 22-23) is concerned with the independence of the recommendations and acknowledgement of possible conflict of interest from the guideline development group. 2. Documentation Appraisers should attempt to identify all information about the guideline development process prior to appraisal. This information may be contained in the same document as the recommendations or it may be summarised in a separate technical report, in published papers or in policy reports (e.g. guideline programmes). We recommend that you read the guideline and its accompanying documentation fully before you start the appraisal. 3. Number of appraisers We recommend that each guideline is assessed by at least two appraisers and preferably four as this will increase the reliability of the assessment. 4. Response scale Each item is rated on a 4-point scale ranging from 4 to 1, with two mid points: 3 Agree and 2 Disagree. The scale measures the extent to which a criterion (item) has been fulfilled. If you are confident that the criterion has been fully met then you should answer. If you are confident that the criterion has not been fulfilled at all or if there is no information available then you should answer. If you are unsure that a criterion has been fulfilled, for example because the information is unclear or because only some of the recommendations fulfil the criterion, then you should answer Agree or Disagree, depending on the extent to which you think the issue has been addressed. 5. User Guide We have provided additional information in the User Guide adjacent to each item. This information is intended to help you understand the issues and concepts addressed by the item. Please read this guidance carefully before giving your response. 4
6 I N STRU C TI O N S F O R USE Please read the following instructions carefully before using the AGREE Instrument. 6. There is a box for comments next to each item. You should use this box to explain the reasons for your responses. For example, you may because the information is not available, the item is not applicable, or the methodology described in the information provided is unsatisfactory. Space for further comments is provided at the end of the instrument. 7. Calculating domain scores Domain scores can be calculated by summing up all the scores of the individual items in a domain and by standardising the total as a percentage of the maximum possible score for that domain. Example: If four appraisers give the following scores for Domain 1 (Scope & purpose): Appraiser 3 Item 1 Item 2 Item 3 Total Appraiser Appraiser Appraiser Appraiser Total Maximum possible score = 4 (strongly agree) x 3 (items) x 4 (appraisers) = 48 Minimum possible score = 1 (strongly disagree) x 3 (items) x 4 (appraisers) = 12 The standardised domain score will be: obtained score minimum possible score = Maximum possible score minimum possible score = = 0.67 x 100 = 67% Note: The six domain scores are independent and should not be aggregated into a single quality score. Although the domain scores may be useful for comparing guidelines and will inform the decision as to whether or not to use or to recommend a guideline, it is not possible to set thresholds for the domain scores to mark a good or bad guideline. 8. Overall assessment A section for overall assessment is included at the end of the instrument. This contains a series of options Strongly recommend, Recommend (with provisos or alterations), Would not recommend and Unsure. The overall assessment requires the appraiser to make a judgement as to the quality of the guideline, taking each of the appraisal criteria into account. 5
7 S C O PE A N D PURP O SE 1. The overall objective(s) of the guideline is (are) specifically described. 2. The clinical question(s) covered by the guideline is(are) specifically described. 3. The patients to whom the guideline is meant to apply are specifically described. 6
8 USER G UIDE S C O PE A N D PURP O SE 1. This deals with the potential health impact of a guideline on society and populations of patients. The overall objective(s) of the guideline should be described in detail and the expected health benefits from the guideline should be specific to the clinical problem. For example specific statements would be: Preventing (long term) complications of patients with diabetes mellitus; Lowering the risk of subsequent vascular events in patients with previous myocardial infarction; Rational prescribing of antidepressants in a cost-effective way. 2. A detailed description of the clinical questions covered by the guideline should be provided, particularly for the key recom mendations (see item 17). Following the examples provided in question 1: How many times a year should the HbA1c be measured in patients with diabetes mellitus? What should the daily aspirin dosage for patients with proven acute myocardial infarction be? Are selective serotonin reuptake inhibitors (SSRIs) more cost-effective than tricyclic antidepressants (TCAs) in treatment of patients with depression? 3. There should be a clear description of the target population to be covered by a guideline. The age range, sex, clinical description, comorbidity may be provided. For example: A guideline on the management of diabetes mellitus only includes patients with non-insulin dependent diabetes mellitus and excludes patients with cardiovascular comorbidity. A guideline on the management of depression only includes patients with major depression, according to the DSM-IV criteria, and excludes patients with psychotic symptoms and children. A guideline on screening of breast cancer only includes women, aged between 50 and 70 years, with no history of cancer and with no family history of breast cancer. 7
9 STAKEH O L DER I N V O LVE M E N T 4. The guideline development group includes individuals from all the relevant professional groups. 5. The patients views and preferences have been sought. 6. The target users of the guideline are clearly defined. 7. The guideline has been piloted among target users. 8
10 USER G UIDE STAKEH O L DER I N V O LVE M E N T 4. This item refers to the professionals who were involved at some stage of the development process. This may include members of the steering group, the research team involved in selecting and reviewing /rating the evidence and individuals involved in formulating the final recommendations. This item excludes individuals who have externally reviewed the guideline (see Item 13). Information about the composition, discipline and relevant expertise of the guideline development group should be provided. 5. Information about patients experiences and expectations of health care should inform the development of clinical guidelines. There are various methods for ensuring that patients perspectives inform guideline development. For example, the development group could involve patients representatives, information could be obtained from patient interviews, literature reviews of patients experiences could be considered by the group. There should be evidence that this process has taken place. 6. The target users should be clearly defined in the guideline, so they can immediately determine if the guideline is relevant to them. For example, the target users for a guideline on low back pain may include general practitioners, neurologists, orthopaedic surgeons, rheumatologists and physiotherapists. 7. A guideline should have been pre-tested for further validation amongst its intended end users prior to publication. For example, a guideline may have been piloted in one or several primary care practices or hospitals. This process should be documented. 9
11 RI G O UR O F DEVEL O P M E N T 8. Systematic methods were used to search for evidence. 9. The criteria for selecting the evidence are clearly described. 10. The methods used for formulating the recommendations are clearly described. 11. The health benefits, side effects and risks have been considered in formulating the recommendations. 10
12 USER G UIDE RI G O UR O F DEVEL O P M E N T 8. Details of the strategy used to search for evidence should be provided including search terms used, sources consulted and dates of the literature covered. Sources may include electronic databases (e.g. MEDLINE, EMBASE, CINAHL), databases of systematic reviews (e.g. the Cochrane Library, DARE), handsearching journals, reviewing conference proceedings and other guidelines (e.g. the US N ational Guideline Clearinghouse, the German Guidelines Clearinghouse). 9. Criteria for including / excluding evidence identified by the search should be provided. These criteria should be explicitly described and reasons for including and excluding evidence should be clearly stated. For example, guideline authors may decide to only include evidence from randomised clinical trials and to exclude articles not written in English. 10. There should be a description of the methods used to formulate the recom mendations and how final decisions were arrived at. Methods include for example, a voting system, formal consensus techniques (e.g. Delphi, Glaser techniques). Areas of disagreement and methods of resolving them should be specified. 11. The guideline should consider health benefits, side effects, and risks of the recommendations. For example, a guideline on the management of breast cancer may include a discussion on the overall effects on various final outcomes. These may include: survival, quality of life, adverse effects, and symptom management or a discussion comparing one treatment option to another. There should be evidence that these issues have been addressed. 11
13 RI G O UR O F DEVEL O P M E N T 12. There is an explicit link between the recommendations and the supporting evidence. 13. The guideline has been externally reviewed by experts prior to its publication. 14. A procedure for updating the guideline is provided. 12
14 USER G UIDE RI G O UR O F DEVEL O P M E N T 12. There should be an explicit link between the recommendations and the evidence on which they are based. Each recommendation should be linked with a list of references on which it is based. 13. A guideline should be reviewed externally before it is published. Reviewers should not have been involved in the development group and should include some experts in the clinical area and some methodological experts. Patients representatives may also be included. A description of the methodology used to conduct the external review should be presented, which may include a list of the reviewers and their affiliation. 14. Guidelines need to reflect current research. There should be a clear statement about the procedure for updating the guideline. For example, a timescale has been given, or a standing panel receives regularly updated literature searches and makes changes as required. 13
15 CLARITY A N D PRESE N TATI O N 15. The recommendations are specific and unambiguous. 16. The different options for management of the condition are clearly presented. 17. Key recommendations are easily identifiable. 18. The guideline is supported with tools for application. 14
16 USER G UIDE CLARITY A N D PRESE N TATI O N 15. A recom mendation should provide a concrete and precise description of which management is appropriate in which situation and in what patient group, as permitted by the body of evidence. An example of a specific recommendation is: Antibiotics have to be prescribed in children of two years or older with acute otitis media if the complaint last longer than three days or if the complaint increase after the consultation despite adequate treatment with painkillers; in these cases amoxycillin should be given for 7 days (supplied with a dosage scheme). An example of a vague recommendation is: Antibiotics are indicated for cases with an abnormal or complicated course. However, evidence is not always clear cut and there may be uncertainty about the best management. In this case the uncertainty should be stated in the guideline. 16. A guideline should consider the different possible options for screening, prevention, diagnosis or treatment of the condition it covers. These possible options should be clearly presented in the guideline. For example, a recom mendation on the management of depression may contain the following alternatives: a. Treatment with TCA b. Treatment with SSRI c. Psychotherapy d. Combination of pharmacological and psychological therapy 17. Users should be able to find the most relevant recom mendations easily. These recom mendations answer the main clinical questions that have been covered by the guideline. They can be identified in different ways. For example, they can be summarised in a box, typed in bold, underlined or presented as flow charts or algorithms. 18. For a guideline to be effective it needs to be disseminated and implemented with additional materials. These may include for example, a sum mary document, or a quick reference guide, educational tools, patients leaflets, computer support, and should be provided with the guideline. 15
17 APPLI C ABILITY 19. The potential organisational barriers in applying the recommendations have been discussed. 20. The potential cost implications of applying the recommendations have been considered. 21. The guideline presents key review criteria for monitoring and /or audit purposes. 16
18 USER G UIDE APPLI C ABILITY 19. Applying the recom mendations may require changes in the current organisation of care within a service or a clinic which may be a barrier to using them in daily practice. Organisational changes that may be needed in order to apply the recom mendations should be discussed. For example: i. A guideline on stroke may recom mend that care should be co-ordinated through stroke units and stroke services. ii. A guideline on diabetes in primary care may require that patients are seen and followed up in diabetic clinics. 20. The recommendations may require additional resources in order to be applied. For example, there may be a need for more specialised staff, new equipment, expensive drug treatment. These may have cost implications for health care budgets. There should be a discussion of the potential impact on resources in the guideline. 21. Measuring the adherence to a guideline can enhance its use. This requires clearly defined review criteria that are derived from the key recom mendations in the guideline. These should be presented. Examples of review criteria are: The HbA1c should be < 8.0%. The level of diastolic blood pressure should be < 95 mmhg. If complaints of acute otitis media lasts longer than three days amoxicillin should be prescribed. 17
19 EDIT O RIAL I N DEPE N DE N CE 22. The guideline is editorially independent from the funding body. 23. Conflicts of interest of guideline development members have been recorded. FURT HER C O M M E N TS 18
20 USER G UIDE EDIT O RIAL I N DEPE N DE N CE 22. Some guidelines are developed with external funding (e.g. Government funding, charity organisations, pharmaceutical companies). Support may be in the form of financial contribution for the whole development, or for parts of it, e.g. printing of the guidelines. There should be an explicit statement that the views or interests of the funding body have not influenced the final recommendations. Please note: If it is stated that a guideline was developed without external funding, then you should answer. 23. There are circumstances when members of the development group may have conflicts of interest. For example, this would apply to a member of the development group whose research on the topic covered by the guideline is also funded by a pharmaceutical company. There should be an explicit statement that all group members have declared whether they have any conflict of interest. FURT HER C O M M E N TS 19
21 O VERALL ASSESS M E N T Would you recommend these guidelines for use in practice? Strongly recommend Recommend (with provisos or alterations) Would not recommend Unsure N O TES 20
22 The AGREE Collaboration. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument.
Draft National Quality Assurance Criteria for Clinical Guidelines
Draft National Quality Assurance Criteria for Clinical Guidelines Consultation document July 2011 1 About the The is the independent Authority established to drive continuous improvement in Ireland s health
More informationNHS. The guideline development process: an overview for stakeholders, the public and the NHS. National Institute for Health and Clinical Excellence
NHS National Institute for Health and Clinical Excellence Issue date: April 2007 The guideline development process: an overview for stakeholders, the public and the NHS Third edition The guideline development
More informationFinal Accreditation Report
Guidance producer: The Royal College of Physicians of London Guidance product: National Clinical Guideline for Stroke Date: 19 September 2016 Version: 1.2 Final Accreditation Report Report Page 1 of 21
More informationClinical Practice Guideline Development Manual
Clinical Practice Guideline Development Manual Publication Date: September 2016 Review Date: September 2021 Table of Contents 1. Background... 3 2. NICE accreditation... 3 3. Patient Involvement... 3 4.
More informationCOMMISSIONING SUPPORT PROGRAMME. Standard operating procedure
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the
More informationHow NICE clinical guidelines are developed
Issue date: January 2009 How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS Fourth edition : an overview for stakeholders, the public and the NHS Fourth edition
More informationClinical guideline for the prevention and treatment of osteoporosis
Guidance producer: National Osteoporosis Guideline Group Guidance product: Clinical guideline for the prevention and treatment of osteoporosis Date: 9 March 2017 Version: 1.3 Final Accreditation Report
More informationFinal Accreditation Report
Guidance producer: Healthcare Infection Society Guidance product: Clinical Guidelines Date: 23 March 2015 Version: 1.6 Final Accreditation Report Page 1 of 19 Contents Introduction... 3 Accreditation recommendation...
More informationNational Institute for Health and Clinical Excellence. The guidelines manual
National Institute for Health and Clinical Excellence The guidelines manual January 2009 The guidelines manual About this document This document describes the methods used in the development of NICE guidelines.
More informationFinal Accreditation Report
Guidance producer: Resuscitation Council (UK) Guidance product: 2010 resuscitation guidelines Date: 2 August 2012 Version: 1.4 Final Accreditation Report Page 1 of 19 Contents Introduction... 3 Accreditation
More informationDoes pay-for-performance improve the quality of health care?
August 2008 SUPPORT Summary of a systematic review Does pay-for-performance improve the quality of health care? Explicit financial incentives have been proposed as a strategy to change physician and healthcare
More informationKNOWLEDGE SYNTHESIS: Literature Searches and Beyond
KNOWLEDGE SYNTHESIS: Literature Searches and Beyond Ahmed M. Abou-Setta, MD, PhD Department of Community Health Sciences & George & Fay Yee Centre for Healthcare Innovation University of Manitoba Email:
More informationEffectively implementing multidisciplinary. population segments. A rapid review of existing evidence
Effectively implementing multidisciplinary teams focused on population segments A rapid review of existing evidence October 2016 Francesca White, Daniel Heller, Cait Kielty-Adey Overview This review was
More informationERN Assessment Manual for Applicants
Share. Care. Cure. ERN Assessment Manual for Applicants 3.- Operational Criteria for the Assessment of Networks An initiative of the Version 1.1 April 2016 History of changes Version Date Change Page 1.0
More informationThe Renal Association
Guidance producer: The Renal Association Guidance product: Clinical Practice Guidelines Date: 11 January 2017 Version: 1.4 Final Accreditation Report Contents Introduction... 3 Accreditation recommendation...
More informationFinal Accreditation Report
Guidance producer: Royal College of Surgeons of England: Surgical Specialty Associations Guidance product: Clinical Commissioning Guides Date: 28 February 2013 Version: 1.3 Final Accreditation Report Royal
More informationWhat information do we need to. include in Mental Health Nursing. Electronic handover and what is Best Practice?
What information do we need to P include in Mental Health Nursing T Electronic handover and what is Best Practice? Mersey Care Knowledge and Library Service A u g u s t 2 0 1 4 Electronic handover in mental
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Principles Interim Process and Methods of the Highly Specialised Technologies Programme 1. Our guidance production processes are based on key principles,
More informationSystematic Review. Request for Proposal. Grant Funding Opportunity for DNP students at UMDNJ-SN
Systematic Review Request for Proposal Grant Funding Opportunity for DNP students at UMDNJ-SN Sponsored by the New Jersey Center for Evidence Based Practice At the School of Nursing University of Medicine
More informationBritish Society for Surgery of the Hand. (BSSH) Evidence for Surgical
British Society for Surgery of the Hand (BSSH) Evidence for Surgical Treatment (B.E.S.T.) Process Manual 1 st Edition (12 th version, November 2016) Review Date: November 2019 BSSH Evidence for Surgical
More informationBritish Association of Dermatologists
Guidance producer: British Association of Dermatologists Guidance product: Service Guidance and Standards Date: 13 March 2017 Version: 1.2 Final Accreditation Report Page 1 of 26 Contents Introduction...
More informationImproving Patient Care through. Clinical Audit. A How To Guide
Improving Patient Care through Clinical Audit A How To Guide 1 CONTENTS PAGE 1. Why do Clinical Audit? 3 2. What is Clinical Audit? 3 3. Clinical Audit and Research 4 4. The Clinical Audit Cycle 5 5. What
More informationOnline Data Supplement: Process and Methods Details
Online Data Supplement: Process and Methods Details ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work
More informationSection 1 What is a guideline? Implementation Toolkit
Section 1 What is a guideline? Guidelines Implementation Toolkit Contents Section 1 What is a guideline? 1.1 Introduction what this resource is for 1.2 What are guidelines? 1.3 Why are clinical guidelines
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate Quality standards Process guide
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and Social Care Directorate Quality standards Process guide December 2014 Quality standards process guide Page 1 of 44 About this guide This guide
More informationCommunity Health Network of San Francisco Committee on Interdisciplinary Practice
Community Health Network of San Francisco Committee on Interdisciplinary Practice Title: Pain Consultation Service - Clinical Pharmacist I. Policy Statement A. It is the policy of the Community Health
More informationQuality Standards. Process and Methods Guide. October Quality Standards: Process and Methods Guide 0
Quality Standards Process and Methods Guide October 2016 Quality Standards: Process and Methods Guide 0 About This Guide This guide describes the principles, process, methods, and roles involved in selecting,
More informationemja: Measuring patient-reported outcomes: moving from clinical trials into clinical p...
Página 1 de 5 emja Australia The Medical Journal of Home Issues emja shop My account Classifieds Contact More... Topics Search From the Patient s Perspective Editorial Measuring patient-reported outcomes:
More informationInstitute of Medicine Standards for Systematic Reviews
Institute of Medicine Standards for Systematic Reviews Christopher H Schmid Tufts University ILSI 23 January 2012 Phoenix, AZ Disclosures Member of Tufts Evidence-Based Practice Center Member, External
More informationPHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK
PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationProcess and methods Published: 30 November 2012 nice.org.uk/process/pmg6
The guidelines manual Process and methods Published: 30 November 2012 nice.org.uk/process/pmg6 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationFinal. Andrew McMylor / Dr Nicola Jones
NHS Standard Contract - Service Specification Service Specification Service Final 24hour Ambulatory Blood Pressure Monitoring (24hrABPM) Commissioner Lead Lead Andrew McMylor / Dr Nicola Jones Jeremy Fenwick,
More informationEducation Adopting and adapting clinical guidelines for local use
Education 2007;9:48 52 10.1576/toag.9.1.048.27296 www.rcog.org.uk/togonline The Obstetrician & Gynaecologist Education Adopting and adapting clinical guidelines for local use Author Gillian C Penney Key
More informationAre you responding as an individual or on behalf of an organisation?
Response form Address: 407 St John Street, London, EC1V 4AD Are you responding as an individual or on behalf of an organisation? If as an individual, are you responding as: a) a doctor? b) a patient? c)
More informationIssue date: June Guide to the methods of technology appraisal
Issue date: June 2008 Guide to the methods of technology appraisal Guide to the methods of technology appraisal Issued: June 2008 This document is one of a set that describes the process and methods that
More informationHigh Level Pharmaceutical Forum
High Level Pharmaceutical Forum 2005-2008 Final Conclusions and Recommendations of the High Level Pharmaceutical Forum On 2 nd October 2008, the High Level Pharmaceutical Forum agreed on the following
More informationInitial education and training of pharmacy technicians: draft evidence framework
Initial education and training of pharmacy technicians: draft evidence framework October 2017 About this document This document should be read alongside the standards for the initial education and training
More informationNICE Charter Who we are and what we do
NICE Charter 2017 Who we are and what we do 1. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing evidence-based guidance on health and
More informationBuilding an infrastructure to improve cardiac rehabilitation: from guidelines to audit and feedback Verheul, M.M.
UvA-DARE (Digital Academic Repository) Building an infrastructure to improve cardiac rehabilitation: from guidelines to audit and feedback Verheul, M.M. Link to publication Citation for published version
More informationNewborn Screening Programmes in the United Kingdom
Newborn Screening Programmes in the United Kingdom This paper has been developed to increase awareness with Ministers, Members of Parliament and the Department of Health of the issues surrounding the serious
More informationNHS Health Check Assessor workbook. to accompany the competence framework
NHS Assessor workbook to accompany the competence framework January 2015 About Public Health England Public Health England exists to protect and improve the nation's health and wellbeing, and reduce health
More informationHealth Research 2017 Call for Proposals. Evaluation process guide
Health Research 2017 Call for Proposals Evaluation process guide Evaluation process guide Health Research 2017 Call for Proposals la Caixa Foundation 0 0 Introduction This guide sets out the procedure
More informationEvaluation of the Threshold Assessment Grid as a means of improving access from primary care to mental health services
Evaluation of the Threshold Assessment Grid as a means of improving access from primary care to mental health services Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation
More information4. Hospital and community pharmacies
4. Hospital and community pharmacies As FIP is the international professional organisation of pharmacists, this paper emphasises the role of the pharmacist in ensuring and increasing patient safety. The
More informationReviewing the literature
Reviewing the literature Smith, J., & Noble, H. (206). Reviewing the literature. Evidence-Based Nursing, 9(), 2-3. DOI: 0.36/eb- 205-02252 Published in: Evidence-Based Nursing Document Version: Peer reviewed
More informationBelmont Forum Collaborative Research Action:
Belmont Forum Collaborative Research Action: SCIENCE-DRIVEN E-INFRASTRUCTURES INNOVATION (SEI) FOR THE ENHANCEMENT OF TRANSNATIONAL, INTERDISCIPLINARY, AND TRANSDISCIPLINARY DATA USE IN ENVIRONMENTAL CHANGE
More informationSupporting information for appraisal and revalidation: guidance for Supporting information for appraisal and revalidation: guidance for ophthalmology
FOREWORD As part of revalidation, doctors will need to collect and bring to their appraisal six types of supporting information to show how they are keeping up to date and fit to practise. The GMC has
More informationMethods: Commissioning through Evaluation
Methods: Commissioning through Evaluation NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Commissioning Strategy
More informationClinical Practice Guidelines in End-Stage Renal Disease: A Strategy for Implementation
SPECIAL REPORT J Am Soc Nephrol 10: 872 877, 1999 Clinical Practice Guidelines in End-Stage Renal Disease: A Strategy for Implementation ALAN S. KLIGER* and WILLIAM E. HALEY *Yale University School of
More informationIntroductie praktijonderzoek Developing indicators to measure pharmaceutical care across nations
Introductie praktijonderzoek WS 2 Developing indicators to measure pharmaceutical care across nations Martina Teichert Experts: Foppe van Mil, Martin Henman, Tommy Westerlund PCNE BLED 2017 Progam Sessions
More informationST PAUL S CATHOLIC PRIMARY SCHOOL AND NURSERY. Supporting Pupils with Medical Conditions Policy
ST PAUL S CATHOLIC PRIMARY SCHOOL AND NURSERY Supporting Pupils with Medical Conditions Policy Our Mission Statement Do everything with love. (St Paul s first letter to the Corinthians 16:14) This means
More informationPCORI s Approach to Patient Centered Outcomes Research
PCORI s Approach to Patient Centered Outcomes Research David H. Hickam, MD, MPH Director, PCORI Clinical Effectiveness and Decision Science Program Charleston, SC July 18, 2017 Goals of this Presentation
More informationMeasure #356: Unplanned Hospital Readmission within 30 Days of Principal Procedure National Quality Strategy Domain: Effective Clinical Care
Measure #356: Unplanned Hospital Readmission within 30 Days of Principal Procedure National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationCLINICAL PRACTICE GUIDElines
ORIGINAL CONTRIBUTION Are Guidelines Following Guidelines? The Methodological Quality of Clinical Practice Guidelines in the Peer-Reviewed Medical Literature Terrence M. Shaneyfelt, MD, MPH Michael F.
More informationabcdefghijklmnopqrstu
Healthcare Policy and Strategy Directorate Quality Division Dear Colleague INTRODUCTION AND AVAILABILITY OF NEWLY LICENSED MEDICINES IN THE NHS IN SCOTLAND Dear Colleague This guidance sets out the policy
More informationJOB DESCRIPTON. Multisystemic Therapy Child Abuse & Neglect (MST-CAN) Supervisor. Therapists, Support Worker, Family Engagement Worker
JOB DESCRIPTON Post Title Multisystemic Therapy Child Abuse & Neglect (MST-CAN) Supervisor Service MST - CAN Job Number Grade 12 Responsible to Programme Manager Responsible for Therapists, Support Worker,
More informationUsing Clinical Practice Guidelines to Improve Patient Care
Using Clinical Practice Guidelines to Improve Patient Care Tosha B. Wetterneck, MD; Mary H. Pak, MD ABSTRACT Clinical practice guidelines incorporate the best available evidence for the management of a
More informationClinical practice guidelines: towards better quality guidelines and increased international collaboration
All rights reserved 0007 0920/03 $25.00 www.bjcancer.com Editorial : towards better quality guidelines and increased international collaboration R Grol*,1, FA Cluzeau 2 and JS Burgers 1 1 University Medical
More informationCochrane Effective Practice and Organisation of Care Review Group DATA COLLECTION CHECKLIST
Cochrane Effective Practice and Organisation of Care Review Group DATA COLLECTION CHECKLIST Page 2 Cochrane Effective Practice and Organisation of Care Review Group (EPOC) CONTENTS Item Data Collection
More informationStroke in Young Adults Funding Opportunity for Mid- Career Researchers. Guidelines for Applicants
Stroke in Young Adults Funding Opportunity for Mid- Career Researchers Guidelines for Applicants 1 Summary This document guides you through the preparation and submission of an application for the Stroke
More informationEUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)
EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) 31 January 2013 1 EUCERD RECOMMENDATIONS ON RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) INTRODUCTION 1. BACKGROUND TO
More informationSupporting information for appraisal and revalidation: guidance for pharmaceutical medicine
Supporting information for appraisal and revalidation: guidance for pharmaceutical medicine Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction The purpose
More informationClinical Coding Policy
Clinical Coding Policy Document Summary This policy document sets out the Trust s expectations on the management of clinical coding DOCUMENT NUMBER POL/002/093 DATE RATIFIED 9 December 2013 DATE IMPLEMENTED
More informationUK Renal Registry 20th Annual Report: Appendix A The UK Renal Registry Statement of Purpose
Nephron 2018;139(suppl1):287 292 DOI: 10.1159/000490970 Published online: July 11, 2018 UK Renal Registry 20th Annual Report: Appendix A The UK Renal Registry Statement of Purpose 1. Executive summary
More informationHow to measure patient empowerment
How to measure patient empowerment Jaime Correia de Sousa Horizonte Family Health Unit Matosinhos Health Centre - Portugal Health Sciences School (ECS) University of Minho, Braga Portugal Aims At the
More informationIntegrated Care Pathways for Child and Adolescent Mental Health Services. Final Standards June Evidence
Integrated Care Pathways for Child and Adolescent Mental Health Services Final Standards June 2011 Evidence Healthcare Improvement Scotland is committed to equality and diversity. We have assessed these
More informationShort Report How to do a Scoping Exercise: Continuity of Care Kathryn Ehrich, Senior Researcher/Consultant, Tavistock Institute of Human Relations.
Short Report How to do a Scoping Exercise: Continuity of Care Kathryn Ehrich, Senior Researcher/Consultant, Tavistock Institute of Human Relations. short report George K Freeman, Professor of General Practice,
More informationEvaluation of Telestroke Services
Evaluation of Telestroke Services 2013 Telestroke Summit Heart and Stroke Foundation of New Brunswick and the Canadian Stroke Network Dr. Patrice Lindsay Director Best Practices and Performance, Stroke
More informationGUIDANCE ON SUPPORTING INFORMATION FOR REVALIDATION FOR SURGERY
ON SUPPORTING INFORMATION FOR REVALIDATION FOR SURGERY Based on the Academy of Medical Royal Colleges and Faculties Core Guidance for all doctors GENERAL INTRODUCTION JUNE 2012 The purpose of revalidation
More informationAcutely ill patients in hospital
Issue date: July 2007 Acutely ill patients in hospital Recognition of and response to acute illness in adults in hospital Developed by the Centre for Clinical Practice at NICE Contents Key priorities for
More informationScottish Medicines Consortium. A Guide for Patient Group Partners
Scottish Medicines Consortium Advising on new medicines for Scotland www.scottishmedicines.org page 1 Acknowledgements Some of the information in this booklet is adapted from guidance produced by the HTAi
More informationCompetencies for NHS Health Check Enhanced Service using the General Level Framework & Service Specification
Competencies for NHS Health Check Enhanced Service using the General Level Framework & Service Specification This is a comprehensive mapping of the GLF against the enhanced service specification (where
More informationEuropean network of paediatric research (EnprEMA)
17 February 2012 EMA/77450/2012 Human Medicines Development and Evaluation Recognition criteria for self assessment The European Medicines Agency is tasked with developing a European paediatric network
More informationNursing skill mix and staffing levels for safe patient care
EVIDENCE SERVICE Providing the best available knowledge about effective care Nursing skill mix and staffing levels for safe patient care RAPID APPRAISAL OF EVIDENCE, 19 March 2015 (Style 2, v1.0) Contents
More information5.3: POLICY FOR THE MANAGEMENT OF REQUESTS FOR MEDICINES VIA PEER APPROVED CLINICAL SYSTEM (PACS) TIER 2
NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 5: NON-FORMULARY PROCESSES 5.3: POLICY FOR THE MANAGEMENT OF REQUESTS FOR MEDICINES VIA PEER APPROVED CLINICAL SYSTEM
More informationTopic I. COURSE DESCRIPTION
PROGRAM: Pharmacy Technician Bridging Education Program COURSE NAME: Pharmacology COURSE DURATION: 33 hours PRIOR LEARNING ASSESSMENT AND RECOGNITION: CH Exam Portfolio N/A I. COURSE DESCRIPTION This course
More informationReport of a Scoping Exercise for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO)
Continuity of Care Report of a Scoping Exercise for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO) Summer 2000 prepared by George Freeman and Sasha Shepperd
More informationPhysiotherapist Registration Board
Physiotherapist Registration Board Standards of Proficiency and Practice Placement Criteria Bord Clárchúcháin na bhfisiteiripeoirí Physiotherapist Registration Board Contents Page Background 2 Standards
More informationNHS Health Check: our approach to the evidence
NHS Health Check: our approach to the evidence Public Health England Wellington House 133-155 Waterloo Road London SE1 8UG www.gov.uk/phe Twitter: @PHE_uk July 2013 NHS Health Check: our approach to the
More informationQuality Measurement Approaches of State Medicaid Accountable Care Organization Programs
TECHNICAL ASSISTANCE TOOL September 2014 Quality Measurement Approaches of State Medicaid Accountable Care Organization Programs S tates interested in using an accountable care organization (ACO) model
More informationV100 Community Practitioner Nurse Prescriber
MODULE SPECIFICATION KEY FACTS Module name V100 Community Practitioner Nurse Prescriber Module code PHM009 School School of Health Sciences Department or equivalent Department of Health Services Research
More informationKnowledge Translation: Cochrane Strategy to disseminate evidence
Knowledge Translation: Cochrane Strategy to disseminate evidence Francesca Gimigliano, MD PhD Cochrane Rehabilitation Communication Committee Chair ISPRM Secretary Associate Professor of PRM University
More information21 March NHS Providers ON THE DAY BRIEFING Page 1
21 March 2018 NHS Providers ON THE DAY BRIEFING Page 1 2016-17 (Revised) 2017-18 (Revised) 2018-19 2019-20 (Indicative budget) 2020-21 (Indicative budget) Total revenue budget ( m) 106,528 110,002 114,269
More informationEgton Medical Information Systems Limited (EMIS) Clinical Immediate Reference articles
Guidance producer: Egton Medical Information Systems Limited (EMIS) Guidance product: Clinical Immediate Reference articles Date: 17 August 2010 Final Accreditation Report Contents Introduction... 3 Accreditation
More informationA Step-by-Step Guide to Tackling your Challenges
Institute for Innovation and Improvement A Step-by-Step to Tackling your Challenges Click to continue Introduction This book is your step-by-step to tackling your challenges using the appropriate service
More informationContinuing NHS Healthcare for Adults in Wales. Preparing you for a CHC Eligibility Meeting
Continuing NHS Healthcare for Adults in Wales Preparing you for a CHC Eligibility Meeting August 2016 Mae r ddogfen yma hefyd ar gael yn Gymraeg. This document is also available in Welsh. Crown copyright
More informationDeveloping a comparative effectiveness research agenda: The CONCERT experience
Developing a comparative effectiveness research agenda: The CONCERT experience David H. Au, MD MS Associate Professor of Medicine University of Washington and Investigator Health Services Research and
More informationMedicines and Healthcare products Regulatory Agency (MHRA) Guidance producer subject to accreditation. Process subject to accreditation
Guidance producer subject to accreditation Process subject to accreditation Medicines and Healthcare products Regulatory Agency (MHRA) Pharmacovigilance Public Assessment Reports Date: 18 June 2010 Draft
More informationDo protocols & guidelines improve care? Prof Dr Marc Sabbe Emergency Department, UZLeuven KULeuven, Belgium
Do protocols & guidelines improve care? Prof Dr Marc Sabbe Emergency Department, UZLeuven KULeuven, Belgium Content Is there a problem? Definitions When do we need guidelines & protocols? Advantages &
More informationRNAO Delirium, Dementia, and Depression in Older Adults: Assessment and Care. Recommendation Comparison Chart
RNAO Delirium, Dementia, and Depression in Older Adults: Assessment and Care Recommendation Comparison Chart RECOMMENDATIONS FROM SCREENING FOR DELIRIUM, DEMENTIA AND DEPRESSION IN THE OLDER ADULT (2010)
More informationSupporting information for appraisal and revalidation: guidance for Occupational Medicine, June 2014
Supporting information for appraisal and revalidation: guidance for Occupational Medicine, June 2014 Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction
More informationPQRS Success in 2015:
PQRS Success in 2015: The Effects of Applicability Validation (MAV) on s Selection for Hospitalists Why is Applicability Validation (MAV) important? CMS requires all eligible professionals (EPs) successfully
More informationSection Title. Prescribing competency framework Catherine Picton, Lead author
Prescribing competency framework Catherine Picton, Lead author What is in this presentation Context Uses of the competency framework Scope of the updated prescribing competency framework Introduction to
More informationSupporting information for appraisal and revalidation: guidance for Occupational Medicine, April 2013
Supporting information for appraisal and revalidation: guidance for Occupational Medicine, April 2013 Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction
More informationSupervision, Accountability & Delegation. date of issue April 2017
Supervision, Accountability & Delegation reference issuing function PD126 Practice & Development date of issue April 2017 0 Supervision, Accountability & Delegation Contents INTRODUCTION... 2 WHAT IS DELEGATION?...
More informationFinal Accreditation Report
Guidance producer: Medicines and Healthcare products Regulatory Agency (MHRA) Guidance product: Device Bulletins Date: 20 September 2010 Final Accreditation Report Page 1 of 21 Contents Introduction...
More informationSupporting information for appraisal and revalidation: guidance for psychiatry
Supporting information for appraisal and revalidation: guidance for psychiatry Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction The purpose of revalidation
More informationYour go to guide on physical activity
Your go to guide on physical activity A Health Professional s guide to physical activity programmes for patients in Greater Glasgow and Clyde Telephone 0141 232 1860 On average, adults should be undertaking
More informationTITLE: Pill Splitting: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
TITLE: Pill Splitting: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines DATE: 05 June 2015 CONTEXT AND POLICY ISSUES Breaking drug tablets is a common practice referred to as pill
More information